David Raymond Koos Age : 62 Public asset : 4,074,564 USD Linked companies : Regen BioPharma, Inc. Summary Founder of Entest Group, Inc., David Raymond Koos is a businessperson who has been at the head of 19 different companies and presently occupies the position of Chairman & Chief Executive Officer for Regen Biopharma, Inc., Chairman, President, CEO, Secretary & Treasurer at Kcl Therapeutics, Inc., Chairman & Chief Executive Officer of BST Partners, Inc., President & Managing Director at Venture Bridge, Inc. and President, Managing Director & Director at Cell Source Research, Inc. David Raymond Koos is also on the board of BMXP Holdings Shareholders Business Trust and AFN Trust.
In his past career he was Chairman, CEO, Secretary & Treasurer at Regen Biopharma, Inc., Chairman, President, CEO, CFO & Secretary at Rivulet Media, Inc. and President & Chief Executive Officer for Tasco Holdings International, Inc. (a subsidiary of Rivulet Media, Inc.), Chairman & Chief Executive Officer at Freedom Environmental Services, Inc. and Chairman & Chief Executive Officer of BMXP Holdings, Inc. (a subsidiary of Freedom Environmental Services, Inc.), Chairman, President, CEO, CFO & Secretary for Entest Group, Inc. Chairman, President, CEO, CFO & Secretary of Entest BioMedical, Inc. and President, CEO, CFO, Secretary & CAO at JB Clothing Corp. (both are subsidiaries of Entest Group, Inc.), Chairman & Chief Executive Officer at Zander Therapeutics, Inc., Chairman, President, CEO, Secretary & Treasurer of SYBLEU, Inc., Chairman & Chief Executive Officer of BST Partners, Inc. (Wyoming), Chairman, Chief Financial Officer & Chairman at Cell Bio-Systems, Inc., Chairman, Chief Executive Officer, CFO & Secretary at Frezer, Inc. and Chairman & Chief Executive Officer for BEFUT International Co. Ltd.
He received a graduate degree from the University of California, Riverside and a doctorate from Atlantic International University.
Current positions of David Raymond Koos Name Title Since Regen BioPharma, Inc. Chairman & Chief Executive Officer 2021 Venture Bridge, Inc. President & Managing Director 2001 Kcl Therapeutics, Inc. Chairman, President, CEO, Secretary & Treasurer 2021 BST Partners, Inc. Chairman & Chief Executive Officer 2018 BMXP Holdings Shareholders Business Trust Trustee - Cell Source Research, Inc. President, Managing Director & Director 2003 AFN Trust Trustee -
Holdings of David Raymond Koos Name Equities % Valuation Regen BioPharma Inc Non Cum Pfd Shs Series A 190,507,442 31.3% 4,000,656 USD Regen Biopharma, Inc. 11,500,000 36.5% 57,500 USD Regen Biopharma, Inc. 3,181,468 0.063% 15,907 USD Regen Biopharma, Inc. 50,000 100.0% 250 USD REGEN BIOPHARMA INC PFD SER NC 50,000 500.0% 250 USD
Market Data 
Markets 
AI
